Hilal Oguz
Overview
Explore the profile of Hilal Oguz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
218
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Karabulut M, Alis H, Bas K, Karabulut S, Afsar C, Oguz H, et al.
Mol Clin Oncol
. 2016 Jan;
3(6):1255-1267.
PMID: 26807230
The present study aimed to investigate the serum levels and clinical relevance of claudin (CLDN) 1 and CLDN7 in patients with colorectal cancer (CRC). A total of 140 patients with...
2.
Karabulut M, Alis H, Afsar C, Karabulut S, Kocatas A, Oguz H, et al.
Biomed Pharmacother
. 2015 Jul;
73:140-6.
PMID: 26211595
Background: Neural precursor cell-expressed, developmentally down regulated 9 (NEDD9), a member of Crk-associated substrate (CAS) family, is highly expressed in multiple cancer types and involved in cancer cell adhesion, migration...
3.
Sen S, Kuru O, Akbayir O, Oguz H, Yasasever V, Berkman S
J Turk Ger Gynecol Assoc
. 2014 Mar;
12(4):214-9.
PMID: 24591997
Objective: Investigation of serum markers which could be used in the malignancy prediction of adnexal masses. Material And Methods: Vascular endothelial growth factor (VEGF), interleukin 6 (IL-6), leptin, C-reactive protein...
4.
Tas F, Duranyildiz D, Oguz H, Camlica H, Yasasever V, Topuz E
Med Oncol
. 2008 Mar;
25(4):431-6.
PMID: 18363112
Vascular endothelial growth factor (VEGF) is a critical regulator of angiogenesis that stimulates proliferation, migration, and metastasis of melanoma. In literature, all studies concerning influences of matrix metalloproteinases (MMPs) and...
5.
Camlica H, Duranyildiz D, Oguz H, Oral E, Yasasever V
Pathol Oncol Res
. 2008 Mar;
14(1):79-83.
PMID: 18347935
The present study was conducted to investigate the sensitivity, specificity, predictive values and accuracy of serum MIF, CEA, CA 19-9 levels and their various combinations in patients with gastric cancer....
6.
Tas F, Duranyildiz D, Oguz H, Camlica H, Yasasever V, Topuz E
Med Oncol
. 2008 Jan;
25(3):346-9.
PMID: 18204821
In this study we have investigated changes in circulating angiogenic factors after a single zoledronic acid intravenous infusion. Thirty consecutive patients who had histologically confirmed breast (n=20) and lung cancer...
7.
Yasasever V, Camlica H, Duranyildiz D, Oguz H, Tas F, Dalay N
Cancer Invest
. 2007 Dec;
25(8):715-9.
PMID: 18058468
The objective of this study was to investigate the expression of macrophage migration inhibitory factor (MIF) in patients with colorectal cancer (GIS) and malignant melanoma (MM). The study group consists...
8.
Tas F, Duranyildiz D, Oguz H, Camlica H, Yasasever V, Topuz E
Melanoma Res
. 2006 Oct;
16(5):405-11.
PMID: 17013089
Angiogenesis is essential for tumor progression and metastasis; however, the angiogenesis regulators that are biologically relevant for melanoma are still unknown. In this study, we analyzed the circulating serum levels...
9.
Tas F, Duranyildiz D, Oguz H, Camlica H, Yasasever V, Topuz E
Cancer Invest
. 2006 Sep;
24(6):576-80.
PMID: 16982461
The characteristic changes in cancer process are assumed to be genetic alterations about the imbalance of cell proliferation and apoptotic cell death. This study was conducted to determine the value...
10.
Tas F, Duranyildiz D, Oguz H, Camlica H, Yasasever V, Topuz E
Cancer Invest
. 2006 Aug;
24(5):492-6.
PMID: 16939957
This study was conducted to determine the value of the angiogenic serum factors, vascular endothelial growth factor (VEGF) and interleukin-8 (IL-8), in patients with small cell lung cancer (SCLC). These...